highly significantp=0.05
The majority of the study population, with ages ranging from 21 to 30 years, experienced post-vaccine menstrual changes, and the results were highly significant (p=0.05).
The majority of the study population, with ages ranging from 21 to 30 years, experienced post-vaccine menstrual changes, and the results were highly significant (p=0.05).